Preprint Interesting Images Version 1 Preserved in Portico This version is not peer-reviewed

Dynamic and Static 18F-FDG PET/CT Imaging in SMARCA4-Deficient Non-small Cell Lung Cancer and Response to Therapy: A Case Report

These authors contributed equally to the work.
Version 1 : Received: 16 May 2023 / Approved: 17 May 2023 / Online: 17 May 2023 (02:37:11 CEST)

A peer-reviewed article of this Preprint also exists.

Wumener, X.; Ye, X.; Zhang, Y.; Jin, S.; Liang, Y. Dynamic and Static 18F-FDG PET/CT Imaging in SMARCA4-Deficient Non-Small Cell Lung Cancer and Response to Therapy: A Case Report. Diagnostics 2023, 13, 2048. Wumener, X.; Ye, X.; Zhang, Y.; Jin, S.; Liang, Y. Dynamic and Static 18F-FDG PET/CT Imaging in SMARCA4-Deficient Non-Small Cell Lung Cancer and Response to Therapy: A Case Report. Diagnostics 2023, 13, 2048.

Abstract

SMARCA4-deficient non-small cell lung cancer (NSCLC) is a more recently recognized subset of NSCLC. We describe the 18F-fluorodeoxyglucose (FDG) PET/CT findings in a rare case of SMARCA4-deficient NSCLC and response to therapy. A 45-year-old male patient with a history of heavy smoking (10 years) underwent an 18F-fluorodeoxyglucose (FDG) PET/CT dynamic (chest) + static (whole-body) scan for diagnosis and pre-treatment staging. 18F-FDG PET/CT showed an FDG-avid mass in the upper lobe of the left lung (SUVmax of 22.4) and FDG-avid lymph nodes (LN) in the left pulmonary hilar region (SUVmax of 5.7). In addition, there are multiple metastases throughout the body, including distant LNs, adrenal glands, bone, and brain. Pathological findings confirmed SMARCA-4 deficient NSCLC. After 4 cycles of chemotherapy and immune checkpoint inhibitors(ICI), the patient underwent again an 18F-FDG PET/CT scan (including dynamic scan) for efficacy evaluation. We report cases that deepen the understanding of the 18F-FDG PET/CT presentation of SMARCA4-deficient NSCLC as well as dynamic imaging features and parametric characteristics.

Keywords

18F-FDG; PET/CT; SMARCA 4; NSCLC; Dynamic imaging;Efficacy evaluation

Subject

Medicine and Pharmacology, Pulmonary and Respiratory Medicine

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.